Wegovy and similar medicines, which belong to a class of drugs known as GLP-1 receptor agonists, can cost more than US$1,000 per month, and may require extended use to yield significant benefits
Tsoi KM, MacParland SA, Ma XZ, Spetzler VN, Echeverri J, Ouyang B, et al
GLP-1 medications like semaglutide protect the brain by improving blood vessel health, reducing inflammation, and potentially impacting metabolic processes linked to Alzheimer's disease
Additionally, Hansoh will receive royalties based on product sales, ensuring long-term benefits
The costs of obesity-related conditions extend well beyond direct medical expensesthey reduce workforce productivity, increase disability rates, and strain insurance programs
Why Choose Premium Healthcare for Weight Loss Management